G.A. Eggimann
The Role of Phosphoglycans in the Susceptibility of Leishmania mexicana to the Temporin Family of Anti-Microbial Peptides
Eggimann, G.A.; Sweeney, K.; Bolt, H.L.; Rozatian, N.; Cobb, S.L.; Denny, P.W.
Authors
K. Sweeney
H.L. Bolt
N. Rozatian
Professor Steven Cobb s.l.cobb@durham.ac.uk
Professor
Professor Paul Denny p.w.denny@durham.ac.uk
Professor
Abstract
Natural product antimicrobial peptides (AMPs) have been proposed as promising agents against the Leishmania species, insect vector borne protozoan parasites causing the neglected tropical disease leishmaniasis. However, recent studies have shown that the mammalian pathogenic amastigote form of L. mexicana, a causative agent of cutaneous leishmaniasis, is resistant to the amphibian-derived temporin family of AMPs when compared to the insect stage promastigote form. The mode of resistance is unknown, however the insect and mammalian stages of Leishmania possess radically different cell surface coats, with amastigotes displaying low (or zero) quantities of lipophosphoglycan (LPG) and proteophosphoglycan (PPG), macromolecules which form thick a glycocalyx in promastigotes. It has been predicted that negatively charged LPG and PPG influence the sensitivity/resistance of promastigote forms to cationic temporins. Using LPG and PPG mutant L. mexicana, and an extended range of temporins, in this study we demonstrated that whilst LPG has little role, PPG is a major factor in promastigote sensitivity to the temporin family of AMPs, possibly due to the conferred anionic charge. Therefore, the lack of PPG seen on the surface of pathogenic amastigote L. mexicana may be implicated in their resistance to these peptides.
Citation
Eggimann, G., Sweeney, K., Bolt, H., Rozatian, N., Cobb, S., & Denny, P. (2015). The Role of Phosphoglycans in the Susceptibility of Leishmania mexicana to the Temporin Family of Anti-Microbial Peptides. Molecules, 20(2), 2775-2785. https://doi.org/10.3390/molecules20022775
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 28, 2015 |
Online Publication Date | Feb 6, 2015 |
Publication Date | Feb 6, 2015 |
Deposit Date | Feb 6, 2015 |
Publicly Available Date | Feb 9, 2015 |
Journal | Molecules |
Electronic ISSN | 1420-3049 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 20 |
Issue | 2 |
Pages | 2775-2785 |
DOI | https://doi.org/10.3390/molecules20022775 |
Keywords | Leishmania mexicana, Cutaneous leishmaniasis, Drug therapy, Antimicrobial peptide. |
Public URL | https://durham-repository.worktribe.com/output/1415072 |
Files
Published Journal Article
(3 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/4.0/).
You might also like
Rapid genotyping of Toxoplasma gondii isolates via Nanopore-based multi-locus sequencing
(2024)
Journal Article
TREATMENT OF LEISHMANIASIS
(2024)
Patent
Clemastine/tamoxifen hybrids as easily accessible antileishmanial drug leads
(2024)
Journal Article